Eijun Nishihara

3.8k total citations · 1 hit paper
112 papers, 2.6k citations indexed

About

Eijun Nishihara is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Eijun Nishihara has authored 112 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Endocrinology, Diabetes and Metabolism, 31 papers in Molecular Biology and 26 papers in Surgery. Recurrent topics in Eijun Nishihara's work include Thyroid Disorders and Treatments (55 papers), Thyroid Cancer Diagnosis and Treatment (51 papers) and Growth Hormone and Insulin-like Growth Factors (15 papers). Eijun Nishihara is often cited by papers focused on Thyroid Disorders and Treatments (55 papers), Thyroid Cancer Diagnosis and Treatment (51 papers) and Growth Hormone and Insulin-like Growth Factors (15 papers). Eijun Nishihara collaborates with scholars based in Japan, United States and China. Eijun Nishihara's co-authors include Akira Miyauchi, Nobuyuki Amino, Ito M, Takumi Kudo, Shuji Fukata, Sumihisa Kubota, Shunichi Yamashita, Yuji Nagayama, Kennichi Kakudo and Mitsuyoshi Hirokawa and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Eijun Nishihara

106 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-Term Outcomes of Active Surveillance and Immediate Surgery for Adult Patients with Low-Risk Papillary Thyroid Microcarcinoma: 30-Year Experience

2023 61 citations Akira Miyauchi, Yasuhiro Ito et al. Thyroid profile →

Peers

Countries citing papers authored by Eijun Nishihara

Since Specialization

Citations

This map shows the geographic impact of Eijun Nishihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eijun Nishihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eijun Nishihara more than expected).

Fields of papers citing papers by Eijun Nishihara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eijun Nishihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eijun Nishihara. The network helps show where Eijun Nishihara may publish in the future.

Co-authorship network of co-authors of Eijun Nishihara

This figure shows the co-authorship network connecting the top 25 collaborators of Eijun Nishihara. A scholar is included among the top collaborators of Eijun Nishihara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eijun Nishihara. Eijun Nishihara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of Minimal Dose Strategy Before Antithyroid Drug Discontinuation on Relapse Risk in Graves’ Disease 2025 ·The Journal of Clinical Endocrinology & Metabolism ·(unknown), Ito M, Hiroyuki Yamaoka, (unknown), Eijun Nishihara, Shuji Fukata, Mitsushige Nishikawa, Akira Miyauchi, Takashi Akamizu	0
2	Treatment of syndrome of resistance to thyroid hormone beta: 2023 consensus statements from the Japan Thyroid Association 2025 ·Sumiyasu Ishii, Kazumichi Onigata, Shigekazu Sasaki, Junta Takamatsu, Tetsuya Tagami, Kyoko Takeda, Matsuo Taniyama, Eijun Nishihara, Yoshitaka Hayashi, Akira Hishinuma, Shuji Fukata, Yoshiharu Murata, Masanobu Yamada	0
3	Comparison of pathophysiology in subclinical hyperthyroidism with different etiologies 2024 ·Endocrine Journal ·(unknown), Ito M, (unknown), (unknown), (unknown), Shuji Fukata, Takumi Kudo, Eijun Nishihara, Mitsushige Nishikawa, Akira Miyauchi, Takashi Akamizu	0
4	Nodule-Specific NRF2-Targeted Upregulation in Patients With KEAP1 Mutations and Familial Nontoxic Multinodular Goiter 2024 ·The Journal of Clinical Endocrinology & Metabolism ·Eijun Nishihara, Shuji Fukata, Mitsuyoshi Hirokawa, Miyoko Higuchi, Ito M, Mitsushige Nishikawa, Akira Miyauchi, Michiko Matsuse, Norisato Mitsutake, (unknown), Akira Hishinuma, Takahiko Kogai, Takashi Akamizu	1
5	Familial Nonautoimmune Hyperthyroidism Due to a TSH Receptor Gene Pathogenic Variant 2024 ·JCEM Case Reports ·(unknown), Eijun Nishihara, Shuji Fukata, Akira Miyauchi, Takashi Akamizu	1
6	Long-Term Outcomes of Active Surveillance and Immediate Surgery for Adult Patients with Low-Risk Papillary Thyroid Microcarcinoma: 30-Year Experience breakdown → 2023 ·Thyroid ·Akira Miyauchi, Yasuhiro Ito, Makoto Fujishima, Akihiro Miya, Naoyoshi Onoda, Minoru Kihara, Takuya Higashiyama, Hiroo Masuoka, (unknown), Takahiro Sasaki, Mitsushige Nishikawa, Shuji Fukata, Takashi Akamizu, Ito M, Eijun Nishihara, (unknown), (unknown), Mitsuyoshi Hirokawa, Toshitetsu Hayashi	61
7	Proportion of serum thyroid hormone concentrations within the reference ranges in athyreotic patients on levothyroxine monotherapy: a retrospective study 2022 ·Thyroid Research ·Ito M, (unknown), (unknown), (unknown), (unknown), Tomohiko Nakamura, Toshihiko Kasahara, Takumi Kudo, Eijun Nishihara, Shuji Fukata, Mitsushige Nishikawa, (unknown), Akira Miyauchi	7
8	IgG4 thyroiditis in the Asian population 2020 ·Gland Surgery ·Yaqiong Li, (unknown), Eijun Nishihara, Kennichi Kakudo	7
9	Hashimoto's Thyroiditis with Increased IgG4-Positive Plasma Cells: Using Thyroid-Specific Diagnostic Criteria May Identify Early Phase IgG4 Thyroiditis 2019 ·Thyroid ·Yaqiong Li, Xinli Wang, Zhiyan Liu, Jiwei Ma, Xiaoyan Lin, Yejun Qin, Eijun Nishihara, Akira Miyauchi, Kennichi Kakudo	17
10	TERT mRNA Expression as a Novel Prognostic Marker in Papillary Thyroid Carcinomas 2019 ·Thyroid ·Aya Tanaka, Michiko Matsuse, Vladimir Saenko, (unknown), Kosho Yamanouchi, (unknown), Hiroshi Yano, Eijun Nishihara, Mitsuyoshi Hirokawa, Keiji Suzuki, Akira Miyauchi, Susumu Eguchi, Ko–ichiro Yoshiura, Shunichi Yamashita, Takeshi Nagayasu, Norisato Mitsutake	47
11	Serum Thyroid Hormone Balance in Levothyroxine Monotherapy-Treated Patients with Atrophic Thyroid After Radioiodine Treatment for Graves' Disease 2019 ·Thyroid ·Ito M, (unknown), (unknown), (unknown), Tomohiko Nakamura, (unknown), (unknown), Toshihiko Kasahara, Takumi Kudo, Eijun Nishihara, Shuji Fukata, Mitsushige Nishikawa, Hirotoshi Nakamura, Akira Miyauchi	9
12	Spontaneous Slowing and Regressing of Tumor Growth in Childhood/Adolescent Papillary Thyroid Carcinomas Suggested by the Postoperative Thyroglobulin-Doubling Time 2018 ·Journal of Thyroid Research ·Toshihiko Kasahara, Akira Miyauchi, Takumi Kudo, Eijun Nishihara, Ito M, Yasuhiro Ito, Minoru Kihara, Akihiro Miya	6
13	Sialic Acid-Binding Immunoglobulin-Like Lectin1 as a Novel Predictive Biomarker for Relapse in Graves' Disease: A Multicenter Study 2017 ·Thyroid ·Koshi Hashimoto, Eijun Nishihara, Masako Matsumoto, Shunichi Matsumoto, Yasuyo Nakajima, Kazutaka Tsujimoto, Hajime Yamakage, Noriko Satoh‐Asahara, Jaeduk Yoshimura Noh, Koichi Ito, Akira Miyauchi, Masatomo Mori, Masanobu Yamada, Yoshihiro Ogawa	5
14	A Novel Germline Mutation of KEAP1 (R483H) Associated with a Non-Toxic Multinodular Goiter 2016 ·Frontiers in Endocrinology ·Eijun Nishihara, Akira Hishinuma, Takahiko Kogai, Nami Takada, Mitsuyoshi Hirokawa, Shuji Fukata, Ito M, Tomonori Yabuta, Mitsushige Nishikawa, Hirotoshi Nakamura, Nobuyuki Amino, Akira Miyauchi	15
15	Effect of the presence of remnant thyroid tissue on the serum thyroid hormone balance in thyroidectomized patients 2015 ·European Journal of Endocrinology ·Ito M, Akira Miyauchi, (unknown), (unknown), (unknown), Akane Ide, Takumi Kudo, Eijun Nishihara, Minoru Kihara, Yasuhiro Ito, Kaoru Kobayashi, Akihiro Miya, Shuji Fukata, Hirotoshi Nakamura, Nobuyuki Amino	36
16	Differentiation of Postpartum Graves' Thyrotoxicosis from Postpartum Destructive Thyrotoxicosis Using Antithyrotropin Receptor Antibodies and Thyroid Blood Flow 2014 ·Thyroid ·Akane Ide, Nobuyuki Amino, (unknown), (unknown), Takumi Kudo, Eijun Nishihara, Ito M, Hirotoshi Nakamura, Akira Miyauchi	35
17	Prevalence of Thyrotropin Receptor Germline Mutations and Clinical Courses in 89 Hyperthyroid Patients with Diffuse Goiter and Negative Anti-Thyrotropin Receptor Antibodies 2013 ·Thyroid ·Eijun Nishihara, Shuji Fukata, Akira Hishinuma, Nobuyuki Amino, Akira Miyauchi	13
18	Distinct histopathological features of Hashimoto's thyroiditis with respect to IgG4-related disease 2012 ·Modern Pathology ·Yaqiong Li, Gengyin Zhou, Takashi Ozaki, Eijun Nishihara, Fumio Matsuzuka, Yanhua Bai, Zhiyan Liu, Emiko Taniguchi, Akira Miyauchi, Kennichi Kakudo	68
19	Benign Thyroid Teratomas Manifest Painful Cystic and Solid Composite Nodules: Three Case Reports and a Review of the Literature 2006 ·Endocrine ·Eijun Nishihara, Akira Miyauchi, Mitsuyoshi Hirokawa, Takumi Kudo, Hidemi Ohye, Ito M, Sumihisa Kubota, Shuji Fukata, Nobuyuki Amino, Kanji Kuma	6
20	Palmitoylation of Human Thyrotropin Receptor: Slower Intracellular Trafficking of the Palmitoylation-Defective Mutant 1998 ·Endocrinology ·Kunihiko Tanaka, Yuji Nagayama, Eijun Nishihara, Hiroyuki Namba, Shunichi Yamashita, Masami Niwa	49

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact